Comorbid CAD and Ventricular Hypertrophy Compromise The Perfusion of Myocardial Tissue at Subcritical Stenosis of Epicardial Coronaries

Eslam Abbas Kobri El Kobba Medical Complex, Cairo, Egypt

Abstract

BACKGROUND: Most studies of CAD revascularization have been based on and reported according to angiographic criteria which don’t consider the relation between the resulting effective flow distal to the stenosis and the demand of a hypertrophied myocardial tissue.

MODEL: Mathematical model of the myocardial perfusion in comorbid CAD and ventricular hypertrophy using Poiseuille’s law. The analysis yields that the curve, which represents the relation between the perfusion and the severity of CAD depending on angiographic and/or angiophysiologic criteria, is shifted to the right by the effect of myocardial tissue hypertrophy. The right shift of said curve, which is directly proportional to the degree of ventricular hypertrophy, indicates that the perfusion of the corresponding myocardial tissue is compromised at angiographically and/or angiophysiologically subsignificant stenosis of the supplying epicardial vessel.

RESULTS: Patients with comorbid CAD and left ventricular hypertrophy are more sensitive to CAD-related hemodynamic changes. They are more prone to develop ischemic complications, than their peers with isolated CAD regarding the same degree of coronary stenosis.

CONCLUSION: Patients with comorbid CAD and ventricular hypertrophy suffer from myocardial hypoperfusion at angiographically and/or angiophysiologically subcritical epicardial stenosis. Accordingly; the comorbidity of both diseases should be considered upon designing of the treatment regime.

Background irritate the nerve endings leading to anginal pain [5]. Combined and ven- tricular hypertrophy are not uncommon; they The treatment strategy for treating CAD both share hypertension, which affects ∼ 26% aims to improve survival and/or relieve of the world population [1], as a risk factor. symptoms [6] including dyspnea and stable arXiv:1801.04008v1 [q-bio.QM] 11 Jan 2018 Accumulation of atheromatous plaques under pectoris. Said strategy usually involves tunica intima of the epicardial arteries restricts anti-anginal medications and/or PCI, or CABG the blood flow to the supplied cardiac tissue. in case of complex CAD and/or left main Chronic high-grade narrowing of the coronary involvement, for achieving those aims. Trials arteries induces subendocardial ischemia show that revascularization by PCI or CABG is during the escalation of the myocardial oxygen more effective than a strategy of medical ther- demand throughout exercise or stress [2]. apy alone, in relieving symptoms like angina The strained myocytes release mediators like and dyspnea. Besides; it improves the quality adenosine and bradykinin [3][4] which in ad- of life by reducing the use of anti-angina drugs dition to stimulating coronary vasodilatation, and increasing exercise capacity [7][8][9][10].

1 However; studies indicate that PCI, as an initial and the demand of a comorbid hypertrophied management strategy in patients with stable myocardial tissue. coronary artery disease, did not reduce the risk of complications as Model or other major cardiovascular events when added to optimal medical therapy [11][12][13]. Hagen-Poiseuille law, which is an analytical so- lution to the Navier-Stokes equation [21], states The guidelines recommend that ad hoc that; the flow rate Q through a coronary vessel PCI should not automatically be applied is directly proportional to the pressure gradi- after angiography [14]; and emphasize the ent ∆P between the aortic root and the right usefulness of optimal medical treatment for atrium; and inversely proportional to the resis- selected patients, which can reduce angina tance R within the vessel. Wherein; the resis- and the risk of myocardial infarction and tance R is inversely proportional to the radius α stroke substantially and prevent progression of the vessel elevated to the fourth power, and of atherosclerosis in the entire vasculature. is directly proportional to the blood viscosity Consequently; the clinical decisions for man- µ and the vessel length ∆l. So, by considering agement of CAD generally need to balance a circular cross-section of the vessel: adherence to guidelines against judgments based on specific patient, operator, social, πα4 Q = ∆P economic, and cultural factors [15]. Generally; 8µ∆l PCI and medical therapy should be viewed as when complementary, rather than opposing, strate- gies [16]. Patients with stable coronary artery 8µ∆l R = disease and functionally significant stenoses, πα4 benefit from the combination therapy of PCI so; plus optimal medical therapy by showing 1 1 Q ∝ ∝ α4 ∝ greater symptomatic improvement [17] and R ∆l decreased the need for urgent revasculariza- tion. However; in patients without ischemia, the outcome appeared to be favorable with the The blood flow, which is a non-Newtonian optimal medical therapy alone [18]. fluid, within the circulation doesn’t imitate precisely this law [22], because said relation For revascularization decisions and recom- is applied on a Newtonian fluid in the mendations; said significant stenosis has been steady laminar flow moving through a long defined by most studies of CAD revasculariza- cylindrical pipe. Still, the law outlines the tion, which have been based on and reported dominant determinants which influence the according to angiographic criteria, as ≥ 70% di- blood flow Q within the vasculature either in ameter narrowing, and/or ≥ 50% for left main physiological or pathological conditions. CAD [19]. Besides; angiophysiological crite- rion, such as an assessment of fractional flow Atherosclerosis commonly affects the epicar- reserve (FFR), has been used in deciding when dial coronary vessels leading to narrowing of revascularization is indicated. Thus, for recom- the vessel caliber αe and increase vascular re- mendations about revascularization, coronary sistance of the supplying vessel Re. While: stenosis with FFR ≤ 0.8 is also considered to be 1 significant [20]. The standard values provided Re ∝ 4 by both methods, and so the revascularization αe decision, don’t consider the relation between the corresponding supplied myocardial seg- the resulting effective flow distal to the stenosis ment doesn’t actually suffer this severe blood

2 flow reduction indicated in the above equation. consequently; the flow rate Q, and so the The vasculature of the coronary circulation is perfusion of myocardial tissue, diminish arranged in-series, in addition to the in-parallel significantly upon subcritical stenosis of arrangement, so that the epicardial vascular re- the supplying epicardial artery during the sistance Re is a segmental resistance. The coro- pathogenesis of CAD. nary circulation can be divided into two com- partments, the large epicardial conduit vessels As mentioned; the identification of clinically- and the resistance vessels, which are typically significant stenosis of an epicardial artery de- less than 300µm in diameter [23]. Whereas the pends on an angiographic criterion, its radius conduit vessels exert little if any resistance to αe, and/or an angiophysiologic criterion, the flow, resistance to flow progressively rises as FFR, which is an absolute number result from the vessel diameter of the resistance vessels de- the ratio of the pressure distal to the lesion, clines from about 300µm in the small arteries to the pressure proximal to the lesion during to less than 100µm in the arteriolar vessels [24]. induced hyperemia [20]. The graphical repre- Therefore; the total resistance to blood flow R sentation of the relation between both these comprises mainly the pre-capillary resistance criteria of the supplying artery and the perfu- Rc, the resistance of microvasculature Rm, and sion of the supplied myocardial tissue follows the negligible resistance of the epicardial or a direct proportional relationship represented conductance vessels Re. by a sigmoid-shaped curve, due to the effect of segmental resistance. Myocardial perfusion R = Rc + Rm + Re ξ describes the blood flow Q in ml/min per cubic centimeter of cardiac muscle volume V.

Q ξ = Narrowing of the radius of the epicardial ves- V sel, due to atheromatous plaque, will increase the resistance in this vessel; but as: According to the relation between the radius Rc + Rm  Re αe of an epicardial coronary artery, as an the impact of mild to moderate increase of angiographic criterion, and the perfusion ξ of the corresponding supplied myocardial tissue the epicardial resistance Re on the overall resistance of the coronary circulation R is represented in Figure 1; the perfusion ξ doesn’t insignificant. decrease significantly with gradual stenosis in isolated CAD until a critical stenotic value φα is reached, wherein the perfusion collapses However; in case of combined coronary relatively. Clinically; said critical value φ is artery disease and ventricular hypertrophy, α defined as ≥ 70% radius α reduction, signifi- both R and R + R are increased. Microan- e e c m cant stenosis [19]. However; in patients with giogenesis is activated during the pathogenesis comorbid CAD and ventricular hypertrophy; of ventricular hypertrophy as a compensatory the curve is shifted to the right indicating mechanism to maintain effective blood supply an increase in the critical stenotic value φ , to the hypertrophied tissue. Accordingly; CAD α so that the perfusion ξ of the corresponding causes an increase in R due to epicardial ar- e supplied myocardial tissue collapses relatively terial stenosis and ventricular hypertrophy in- at a clinically subsignificant stenosis. The right creases R + R due to neomicroangiogenesis, c m shift in said patients depends on the degree of i.e. addition of a new microvascular segment. ventricular hypertrophy. 1 R ∝ ∝ ∆l c+m 4 Additionally; the relation between another αm

3 angiophysiologic criterion, the fractional flow patency in patients with comorbid CAD and reserve FFR, within a stenotic epicardial artery ventricular hypertrophy x8 is: and the perfusion ξ of the corresponding supplied myocardial tissue, as represented x8 = x + (ω∆M) in Figure 2, indicates that the perfusion ξ is not meaningfully reduced with the gradual Results decrease of FFR until a critical value φFFR is reached, wherein the perfusion ξ collapses Individuals with pathological ventricular relatively. Clinical trials defined said critical hypertrophy are more sensitive to haemody- value φ as a FFR ≤ 0.8 [25][26]. Though; in FFR namic changes of the coronary circulation or patients with combined CAD and ventricular pathologies that reduce the coronary reserve. hypertrophy; the curve shows a right shift, Ventricular hypertrophy stresses the subendo- which is directly proportional to the degree of cardial myotissue due to increase the structural ventricular hypertrophy, indicating an increase resistance of the coronary circulation. Said in the critical stenotic value φ , so that the FFR stress is ameliorated by compensatory func- perfusion ξ of the corresponding supplied tional changes to sustain the normal coronary myocardial tissue collapses relatively at a blood flow. Although during vigorous exercise, clinically subsignificant reduction in the FFR. the compensatory capability of the coronary flow reserve is exhausted under the effect The proposed model gives a more sensitive of demand upsurge and shortened diastolic formula to detect the critical stenosis, which period. Occasional hemodynamic disturbances takes into account the demand of the supplied or subclinical pathologies which lessen the bulky myocardium. The isolated CAD curve maximum coronary reserve may lead to is a logistic function; wherein x represents the selective subendocardial hypoperfusion. critical stenosis and k is the curve slope:

1 Comorbid CAD and ventricular hypertro- f (x) = 1 + e−kx phy cause the subendocardial tissue to suffer, during exercise or stress, from ischemia at in patients with comorbid CAD and ventricular an angiographically subsignificant stenosis hypertrophy; the curve is shifted to the right by in the supplying epicardial artery. CAD a yielding x8 as a representation of the critical primes the structural resistance of the neomi- stenosis: crovasculature of the hypertrophied tissue. 1 So; subcritical stenosis of the corresponding f (x) = 1 + e−k(x8−a) epicardial artery, mainly due to atherosclerosis, causes the total resistance to rise effectively to then; reduce the flow rate and exhaust the reactive compensatory mechanisms. The curve shift x8 = x + a to the right in said patients doesn’t affect the wherein the curve shift a is directly propor- risk of myocardial infarction, yet they are tional to the difference in muscle bulk ∆M more susceptible to and usually presented which obtained by Echocardiogram; by NSTEMI; with higher rates of transition from ischemia to necrosis in the affected a ∝ ∆M hypertrophied endocardial tissue. Increased muscle bulk shifts the endocardium away from the main blood supply. Besides; subjection a = ω∆M to higher extravascular pressure depletes the the value of the constant ω can be obtained ex- functional vasodilator reserve in long standing perimentally. So; the percentage of the critical pathological hypertrophy.

4 consider the relation between the resulting Patients with combined CAD and ventricu- effective flow distal to the stenosis and the lar hypertrophy have a higher risk to develop demand of a hypertrophied myocardial tissue. arrhythmias than their peers who suffer from isolated CAD. In pathological hypertrophy; The pathogenesis of ventricular hypertrophy the neomicroangiogenesis shows anatomical implicates an increase in the number of and architectural dysgenesis in relation to the force-generating sarcomeres in the myocyte hypertrophied tissue. Said dysgenesis leads to [28]. According to La Place law; an increase failure of the coronary bed to uniformly supply in pressure can be offset by an increase in the cardiac muscle, rendering foci within the wall thickness [29]. This mechanical input hypertrophied muscle bulk at greater risk of is transduced into a biochemical sequel that ischemic injury. These stressed foci can be ar- modifies gene transcription in the nucleus. rhythmogenic upon increased cardiac demand The focal adhesion complex, in addition to leading to serious arrhythmia and sudden car- the G-coupled neurohormonal augmentation diac death. [30], is proposed as the effector transducers of said mechanical input [31]. Integrins connect Discussion the internal cytoskeleton of the cell to the extracellular matrix, wherein multiple tyrosine- During ; the main phosphorylated kinases and serine-threonine determinants of revascularization therapy kinases that are implicated in the signaling of in CAD patients, are either angiographic hypertrophy can be found in the ECM [32][33]. or angiophysiological criteria, measured during drug induced hyperemia, to identify Angiogenesis is triggered during the the clinically-significant stenosis. Said de- pathogenesis of myocardial hypertrophy by terminants depend on the relation between increased cardiac work and oxygen demand; the size of the insinuated plaque and the in an attempt to normalize maximal my- vascular diameter. A stenosis which reduces ocardial perfusion and capillary domains the radius of the epicardial vessel by 70% is to sustain oxygen delivery. A limitation considered significant angiographically. In of capillary growth will increase diffusion another determinant; a small sensor on the distance for oxygen, while inadequate ar- tip of the guidewire is used to measure the teriolar growth will reduce maximal tissue pressure, temperature and flow to determine perfusion. Pathogenesis of hypertrophy is the exact severity of the lesion. The ratio categorized into pressure overload-induced, between the pressure distal to the lesion and volume overload-induced, thyroxin-induced the pressure proximal to the lesion, which and exercise-induced models according to is the fraction flow reserve FFR, measures the stimulus for increasing muscle bulk. the pressure drop caused by the stenosis. In exercise-induced and thyroxin-induced A fraction flow reserve value ≤ 0.8 defines models; angiogenesis and arteriogenesis are the stenosis to be significant. The FFR is a well documented experimentally [34]. While better method to detect the physiological in other models; there is a considerable significance of a stenosis [27], as it takes into variation in the reports of the literature about account collateral flow, which can render an the extent and pattern of angiogenesis and anatomical blockage functionally unimportant. the consequential coronary microvascular Also, standard angiography can underestimate resistance. The reasons for the discrepancy or overestimate narrowing, because it only between these studies are not evident, but the visualizes contrast inside a vessel. Yet; the duration of the hypertrophy and the specificity standard values provided by both methods to of the stimulus may play a role. identify a stenotic lesion as significant, don’t

5 Mathematically; angiogenesis increases the higher rates of transition from ischemia to coronary microvascular resistance structurally, necrosis in the affected endocardial tissue, due to the addition of a new microvascular due to increase diffusion distance for oxygen segment. However, in vivo; structural resis- and exhaustion of the functional compensa- tance can be modulated by functional changes, tion. They are also more susceptible to and wherein autoregulatory adjustments involving usually presented by NSTEMI, due to the the vasodilator reserve may ameliorate said sensitivity of the endocardial myotissue to the structural resistance escalation. Well-trained equilibrium between the structural resistance athletes with physiological cardiac hypertro- of microvasculature and the reactive functional phy show a proportional increase of cardiac modulation. myocytes and coronary vasculature with no change in the proportion of extracellular Myocardial ischemia is characterized by collagen [35]. These structural modulations ionic and biochemical alterations, creating an are accompanied by functional adaptations unstable electrical substrate capable of initi- resulting in a compensatory exponential ating and sustaining arrhythmias [43]. Theo- coronary reserve and vasodilator capacity. retically; onerous angiogenesis in pathological Functional adaptations can include changes hypertrophy shows patterns of anatomical and in neurohumoral control and changes in local architectural dysgenesis rendering foci within vascular control mechanisms [36][37]. In the hypertrophied muscle bulk at greater risk pathological severe hypertrophy; pathological of ischemic injury. Said stressed foci acquire features of the strained neoangiogenesis different electrochemical properties, due to de- halt the functional compensation for the fective function of ATPase-dependent pumps, structural increase in the microvascular resis- leading to tissue heterogeneity. Theses foci tance. Endothelium-dependent is become arrhythmogenic, especially with in- markedly impaired in the coronary microves- creased cardiac demand during above-normal sels of patients with hypertension-induced exercise or severe stressful conditions, lead- ventricular hypertrophy [38]. Accordingly; ing to functional re-entry. Hence; presence of severe ventricular hypertrophy is associated ventricular hypertrophy is associated with a with a reduction in coronary vascular reserve greater risk of sustained arrhythmias [44]. [39].

Myocardial infarction is mainly caused Conclusion by rupture of vulnerable fibroatheromatous plaque forming a thrombus that interferes The mathematical model establishes that ven- with myocardial blood supply leading to tricular hypertrophy increases the vascular excessive ischemia then necrosis [40]. Usually; structural resistance of the coronary circulation soft non-stenotic plaques are more susceptible due to neomicroangiogenesis. Patients with to rupture, causing major cardiovascular comorbid CAD and ventricular hypertrophy events [41]. The vulnerability of the plaque suffer, due to exhaustion of functional compen- depends on lesion-specific characteristics sation, from complications of myocardial hy- like thin fibrous cap, large lipid-rich necrotic poperfusion at angiographically sub-significant core, increased plaque inflammation, positive coronary artery stenosis. These patients are vascular remodeling, increased vasa-vasorum more susceptible to NSTEMI, serious arrhyth- neovascularization, and intra-plaque hemor- mias and sudden cardiac death than patients rhage [42]. Therefore; the comorbidity between with isolated CAD. Upon confirmation of such CAD and ventricular hypertrophy doesn’t results by large investigational studies, said affect the risk of developing MI. However; results should be taken into account during de- patients with said comorbid diseases have signing the treatment strategy of said patients.

6 Acknowledgement [7] DA Chamberlain, KAA Fox, RA Hender- son, DG Julian, et al. Coronary angio- The author states that there is no conflict of plasty versus medical therapy for angina: interest regarding this article. the second randomised intervention treat- ment of angina (rita-2) trial. The Lancet, References 350(9076):461, 1997. [8] Time Investigators et al. Trial of invasive [1] Patricia M Kearney, Megan Whelton, versus medical therapy in elderly patients Kristi Reynolds, Paul Muntner, Paul K with chronic symptomatic coronary-artery Whelton, and Jiang He. Global burden of disease (time): a randomised trial. The hypertension: analysis of worldwide data. Lancet, 358(9286):951–957, 2001. The lancet, 365(9455):217–223, 2005. [9] William S Weintraub, John A Spertus, [2] Peter Libby and Pierre Theroux. Patho- Paul Kolm, David J Maron, Zefeng Zhang, physiology of coronary artery disease. Cir- Claudine Jurkovitz, Wei Zhang, Pamela M culation, 111(25):3481–3488, 2005. Hartigan, Cheryl Lewis, Emir Veledar, et al. Effect of pci on quality of life in pa- [3] Noam Safran, Vladimir Shneyvays, Nis- tients with stable coronary disease. New sim Balas, Kenneth A Jacobson, Hermann England Journal of Medicine, 359(7):677–687, Nawrath, and Asher Shainberg. Cardio- 2008. protective effects of adenosine a1 and a 3 receptor activation during hypoxia in iso- [10] Paul Erne, Andreas W Schoenenberger, lated rat cardiac myocytes. Molecular and Dieter Burckhardt, Michel Zuber, Wolf- cellular biochemistry, 217(1):143–152, 2001. gang Kiowski, Peter T Buser, Paul Dubach, Therese J Resink, and Matthias Pfisterer. [4] James R Parratt, Agnes Vegh, I Jack Zeitlin, Effects of percutaneous coronary interven- Maqsood Ahmad, Keith Oldroyd, Karoly tions in silent ischemia after myocardial Kaszala, and Julius Gy Papp. Bradykinin infarction: the swissi ii randomized con- and endothelial-cardiac myocyte interac- trolled trial. Jama, 297(18):1985–1991, 2007. tions in ischemic preconditioning. The American journal of cardiology, 80(3):124A– [11] William E Boden, Robert A O’rourke, 131A, 1997. Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudt- [5] Filippo Crea, Giuseppe Pupita, Alfredo R son, Marcin Dada, Paul Casperson, Crys- Galassi, Hassan El-Tamimi, Juan Carlos tal L Harris, et al. Optimal medical Kaski, Graham Davies, and Attilio Maseri. therapy with or without pci for stable Role of adenosine in pathogenesis of angi- coronary disease. New England journal of nal pain. Circulation, 81(1):164–172, 1990. medicine, 356(15):1503–1516, 2007.

[6] William Wijns, Philippe Kolh, Nicolas [12] Whady Hueb, Paulo R Soares, Bernard J Danchin, Carlo Di Mario, Volkmar Falk, Gersh, Luiz AM César, Protásio L Luz, Thierry Folliguet, Scot Garg, Kurt Huber, Luiz B Puig, Eulógio M Martinez, Ser- Stefan James, Juhani Knuuti, et al. Guide- gio A Oliveira, and José AF Ramires. The lines on myocardial revascularization: the medicine, angioplasty, or surgery study task force on myocardial revascularization (mass-ii): a randomized, controlled clini- of the european society of cardiology (esc) cal trial of three therapeutic strategies for and the european association for cardio- multivessel coronary artery disease: one- thoracic surgery (eacts). European heart year results. Journal of the American College journal, 31(20):2501–2555, 2010. of Cardiology, 43(10):1743–1751, 2004.

7 [13] Kathleen Stergiopoulos and David L [19] Glenn N Levine, Eric R Bates, James C Brown. Initial coronary stent implanta- Blankenship, Steven R Bailey, John A tion with medical therapy vs medical ther- Bittl, Bojan Cercek, Charles E Cham- apy alone for stable coronary artery dis- bers, Stephen G Ellis, Robert A Guy- ease: meta-analysis of randomized con- ton, Steven M Hollenberg, et al. 2011 trolled trials. Archives of internal medicine, accf/aha/scai guideline for percutaneous 172(4):312–319, 2012. coronary intervention: executive sum- mary: a report of the american college [14] Stephan Windecker, Philippe Kolh, F Al- of cardiology foundation/american heart fonso, JP Collet, J Cremer, V Falk, G Filip- association task force on practice guide- patos, C Hamm, SJ Head, P Jüni, et al. Au- lines and the society for cardiovascular an- thors/task force members. 2014 esc/eacts giography and interventions. Journal of the guidelines on myocardial revasculariza- American College of Cardiology, 58(24):2550– tion: the task force on myocardial revas- 2583, 2011. cularization of the european society of cardiology (esc) and the european asso- [20] Nico HJ Pijls, Bernard de Bruyne, Ka- ciation for cardio-thoracic surgery (eacts) thinka Peels, Pepijn H van der Voort, developed with the special contribution of Hans JRM Bonnier, Jozef Bartunek, and the european association of percutaneous Jacques J Koolen. Measurement of frac- cardiovascular interventions (eapci). Eur tional flow reserve to assess the functional Heart J, 35(37):2541–2619, 2014. severity of coronary-artery stenoses. New England Journal of Medicine, 334(26):1703– [15] Andre Lamy, Madhu Natarajan, and 1708, 1996. Salim Yusuf. Medical treatment, pci, or cabg for coronary artery disease?, 2011. [21] Henrik Bruus. Theoretical microfluidics. Ox- [16] Roger S Blumenthal, Gregory Cohn, and ford university press Oxford, 2007. Steven P Schulman. Medical therapy ver- sus coronary angioplasty in stable coro- [22] Richard Klabunde. Cardiovascular phys- nary artery disease: a critical review of the iology concepts. Lippincott Williams & literature. Journal of the American College of Wilkins, 2011. Cardiology, 36(3):668–673, 2000. [23] Heinrich R Schelbert. Anatomy and phys- [17] Seema Pursnani, Frederick Korley, Ravin- iology of coronary blood flow. Journal of dra Gopaul, Pushkar Kanade, Newry nuclear cardiology, 17(4):545–554, 2010. Chandra, Richard E Shaw, and Sripal Ban- galore. Percutaneous coronary interven- [24] Judy M Muller, Michael J Davis, and tion versus optimal medical therapy in William M Chilian. Integrated regula- stable coronary artery disease. Circula- tion of pressure and flow in the coronary tion: Cardiovascular Interventions, pages microcirculation. Cardiovascular research, CIRCINTERVENTIONS–112, 2012. 32(4):668–678, 1996.

[18] Bernard De Bruyne, Nico HJ Pijls, Bindu [25] Pim AL Tonino, Bernard De Bruyne, Kalesan, Emanuele Barbato, Pim AL Nico HJ Pijls, Uwe Siebert, Fumiaki Ikeno, Tonino, Zsolt Piroth, Nikola Jagic, Sven Marcel vant Veer, Volker Klauss, Ganesh Möbius-Winkler, Gilles Rioufol, Nils Witt, Manoharan, Thomas Engstrøm, Keith G et al. Fractional flow reserve–guided pci Oldroyd, et al. Fractional flow reserve versus medical therapy in stable coronary versus angiography for guiding percuta- disease. New England Journal of Medicine, neous coronary intervention. N Engl j Med, 367(11):991–1001, 2012. 2009(360):213–224, 2009.

8 [26] Nico HJ Pijls, Pepijn van Schaarden- [33] Louis Terracio, Kristofer Rubin, Donald burgh, Ganesh Manoharan, Eric Boersma, Gullberg, ED Balog, Wayne Carver, Ron Jan-Willem Bech, Marcel vanâA˘ Zt´ Veer, Jyring, and Thomas K Borg. Expression of Frits Bär, Jan Hoorntje, Jacques Koolen, collagen binding integrins during cardiac William Wijns, et al. Percutaneous coro- development and hypertrophy. Circulation nary intervention of functionally non- research, 68(3):734–744, 1991. significant stenosis: 5-year follow-up of the defer study. Journal of the American Col- [34] Robert J Tomanek and Eduard I Dedkov. lege of Cardiology, 49(21):2105–2111, 2007. Angiogenesis and arteriogenesis in car- diac hypertrophy. Modern concepts in an- [27] Nico HJ Pijls, William F Fearon, Pim AL giogenesis, pages 253–280, 2007. Tonino, Uwe Siebert, Fumiaki Ikeno, Bern- hard Bornschein, Marcel van’t Veer, Volker [35] Dirk J Duncker and Robert J Bache. Regu- Klauss, Ganesh Manoharan, Thomas En- lation of coronary blood flow during exer- gstrøm, et al. Fractional flow reserve cise. Physiological reviews, 88(3):1009–1086, versus angiography for guiding percuta- 2008. neous coronary intervention in patients with multivessel coronary artery disease: [36] M HAROLD Laughlin. Effects of exercise 2-year follow-up of the fame (fractional training on coronary transport capacity. Journal of Applied Physiology flow reserve versus angiography for mul- , 58(2):468–476, tivessel evaluation) study. Journal of the 1985. American College of Cardiology , 56(3):177– [37] M Harold Laughlin. Physical activity in 184, 2010. prevention and treatment of coronary dis- [28] Beverly H Lorell and Blase A Carabello. ease: the battle line is in exercise vascular Left ventricular hypertrophy. Circulation, cell biology. Medicine & Science in Sports & 102(4):470–479, 2000. Exercise, 36(3):352–362, 2004.

[29] Stephen Gunther and William Grossman. [38] Charles B Treasure, J Larry Klein, Determinants of ventricular function in Joseph A Vita, Steven V Manoukian, pressure-overload hypertrophy in man. George H Renwick, Andrew P Selwyn, Circulation, 59(4):679–688, 1979. Peter Ganz, and R Wayne Alexander. Hypertension and left ventricular hy- [30] Peter H Sugden. Signaling in myocar- pertrophy are associated with impaired dial hypertrophy. Circulation Research, endothelium-mediated relaxation in hu- 84(6):633–646, 1999. man coronary resistance vessels. Circula- tion, 87(1):86–93, 1993. [31] TK Borg and ML Burgess. Holding it all together: organization and function (s) of [39] August D Pichard, Richard Gorlin, Harry the extracellular matrix in the heart. Heart Smith, John Ambrose, and Jose Meller. Failure, 8:230–230, 1992. Coronary flow studies in patients with left ventricular hypertrophy of the hyper- [32] Dhandapani Kuppuswamy, Charlene tensive type: evidence for an impaired Kerr, Takahiro Narishige, Vijayku- coronary vascular reserve. The American mar S Kasi, Donald R Menick, and journal of cardiology, 47(3):547–554, 1981. George Cooper. Association of tyrosine- phosphorylated c-src with the cytoskele- [40] Grant W Reed, Jeffrey E Rossi, and ton of hypertrophying myocardium. Christopher P Cannon. Acute myocardial Journal of Biological Chemistry, 272(7):4500– infarction. The Lancet, 389(10065):197–210, 4508, 1997. 2017.

9 [41] Peter Libby. Mechanisms of acute coro- nary syndromes and their implications for therapy. New England Journal of Medicine, 368(21):2004–2013, 2013.

[42] Pedro R Moreno. Vulnerable plaque: defi- nition, diagnosis, and treatment. Cardiol- ogy clinics, 28(1):1–30, 2010.

[43] AV Ghuran and AJ Camm. Ischaemic heart disease presenting as arrhythmias. British medical bulletin, 59(1):193–210, 2001.

[44] Saurav Chatterjee, Chirag Bavishi, Partha Sardar, Vikram Agarwal, Parasuram Kr- ishnamoorthy, Tomasz Grodzicki, and Franz H Messerli. Meta-analysis of left ventricular hypertrophy and sustained ar- rhythmias. The American journal of cardiol- ogy, 114(7):1049–1052, 2014.

10 Figure 1: A graphical representation of the relation between the ratio of the perfusion of myocar- dial tissue supplied by a stenotic epicardial coronary ξa, to the perfusion in case of hypothetical absence of stenosis ξo; and the ratio of the radius of said stenotic artery (αe)a, to the radius in case of hypothetical absence of stenosis (αe)o. Both ratios are presented by absolute numbers. In isolated CAD; the direct proportional relationship is represented by a sigmoid-shaped curve, wherein the perfusion of myocardial tissue supplied by said stenotic epicardial coronary ξa collapse relatively at a critical stenotic value φα. Comorbid CAD and ventricular hypertrophy shift the curve to the right leading to an increase in the critical stenotic value φα.

11 Figure 2: A graphical representation of the relation between the ratio of the perfusion of myocar- dial tissue supplied by a stenotic epicardial coronary ξa, to the perfusion in case of hypothetical absence of stenosis ξo; and FFR which is the ratio of the pressure distal to the stenosis Pa, to the pressure proximal to the stenosis Po. Both ratios are presented by absolute numbers. In isolated CAD; the direct proportional relationship is represented by a sigmoid-shaped curve, wherein the perfusion of myocardial tissue supplied by said stenotic epicardial coronary ξa collapse relatively at a critical stenotic value φFFR. Comorbid CAD and ventricular hypertrophy shift the curve to the right leading to an increase in the critical stenotic value φFFR.

12